|
3WWS
Crystal structure of Serine/threonine-protein kinase 3
Deposited 2014-06-27
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
436–484(49 aa)
Fragment:UNP residues 436-484
Chain B
436–484(49 aa)
Fragment:UNP residues 436-484
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;0.1M Tris-HCl pH 7.4. 10%(m/v) PEG3350, 0.1M (NH4)3PO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.01 Å
R-free 0.311
|
|
3WWS
Crystal structure of Serine/threonine-protein kinase 3
Deposited 2014-06-27
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
436–484(49 aa)
Fragment:UNP residues 436-484
Chain D
436–484(49 aa)
Fragment:UNP residues 436-484
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;0.1M Tris-HCl pH 7.4. 10%(m/v) PEG3350, 0.1M (NH4)3PO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.01 Å
R-free 0.311
|
|
4HKD
Crystal structure of human MST2 SARAH domain
Deposited 2012-10-15
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
436–484(49 aa)
Fragment:SARAH DOMAIN, UNP residues 436-484
Chain B
436–484(49 aa)
Fragment:SARAH DOMAIN, UNP residues 436-484
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;289 K;0.4M calcium chloride dihydrate, 0.1M sodium acetate trihydrate, 5%(v/v) 2-propanol, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 1.50 Å
R-free 0.231
|
|
4HKD
Crystal structure of human MST2 SARAH domain
Deposited 2012-10-15
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
436–484(49 aa)
Fragment:SARAH DOMAIN, UNP residues 436-484
Chain D
436–484(49 aa)
Fragment:SARAH DOMAIN, UNP residues 436-484
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;289 K;0.4M calcium chloride dihydrate, 0.1M sodium acetate trihydrate, 5%(v/v) 2-propanol, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 1.50 Å
R-free 0.231
|
|
4LG4
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
16–313(298 aa)
Fragment:kinase domain, UNP residues 16-313
|
Mutation:D146N
|
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.7;277 K;0.2 M sodium citrate, 15% (w/v) PEG 3350, 0.1 M HEPES, pH 7.7, vapor diffusion, hanging drop, temperature 277K
|
Resolution 2.42 Å
R-free 0.231
|
|
4LG4
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
16–313(298 aa)
Fragment:kinase domain, UNP residues 16-313
|
Mutation:D146N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.7;277 K;0.2 M sodium citrate, 15% (w/v) PEG 3350, 0.1 M HEPES, pH 7.7, vapor diffusion, hanging drop, temperature 277K
|
Resolution 2.42 Å
R-free 0.231
|
|
4LG4
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
16–313(298 aa)
Fragment:kinase domain, UNP residues 16-313
|
Mutation:D146N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.7;277 K;0.2 M sodium citrate, 15% (w/v) PEG 3350, 0.1 M HEPES, pH 7.7, vapor diffusion, hanging drop, temperature 277K
|
Resolution 2.42 Å
R-free 0.231
|
|
4LG4
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
16–313(298 aa)
Fragment:kinase domain, UNP residues 16-313
|
Mutation:D146N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.7;277 K;0.2 M sodium citrate, 15% (w/v) PEG 3350, 0.1 M HEPES, pH 7.7, vapor diffusion, hanging drop, temperature 277K
|
Resolution 2.42 Å
R-free 0.231
|
|
4LG4
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
16–313(298 aa)
Fragment:kinase domain, UNP residues 16-313
|
Mutation:D146N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.7;277 K;0.2 M sodium citrate, 15% (w/v) PEG 3350, 0.1 M HEPES, pH 7.7, vapor diffusion, hanging drop, temperature 277K
|
Resolution 2.42 Å
R-free 0.231
|
|
4LG4
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain F
16–313(298 aa)
Fragment:kinase domain, UNP residues 16-313
|
Mutation:D146N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.7;277 K;0.2 M sodium citrate, 15% (w/v) PEG 3350, 0.1 M HEPES, pH 7.7, vapor diffusion, hanging drop, temperature 277K
|
Resolution 2.42 Å
R-free 0.231
|
|
4LGD
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
9–313(305 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain A
428–491(64 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
|
Mutation:D146N
Mutation:D146N
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M Bis-Tris propane, 200 mM Na2SO4, 20% (w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.05 Å
R-free 0.244
|
|
4LGD
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
9–313(305 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain C
428–491(64 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
|
Mutation:D146N
Mutation:D146N
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 1
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M Bis-Tris propane, 200 mM Na2SO4, 20% (w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.05 Å
R-free 0.244
|
|
4LGD
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
9–313(305 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain D
428–491(64 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
|
Mutation:D146N
Mutation:D146N
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 3
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M Bis-Tris propane, 200 mM Na2SO4, 20% (w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.05 Å
R-free 0.244
|
|
4LGD
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
9–313(305 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain B
428–491(64 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
|
Mutation:D146N
Mutation:D146N
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M Bis-Tris propane, 200 mM Na2SO4, 20% (w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.05 Å
R-free 0.244
|
|
4LGD
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
9–313(305 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain A
428–491(64 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain B
9–313(305 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain B
428–491(64 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
|
Mutation:D146N
Mutation:D146N
Mutation:D146N
Mutation:D146N
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M Bis-Tris propane, 200 mM Na2SO4, 20% (w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.05 Å
R-free 0.244
|
|
4LGD
Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Deposited 2013-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
9–313(305 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain C
428–491(64 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain D
9–313(305 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
Chain D
428–491(64 aa)
Fragment:kinase domain, SARAH domain, UNP residues 1-313, 428-491
|
Mutation:D146N
Mutation:D146N
Mutation:D146N
Mutation:D146N
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 4
NA SODIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M Bis-Tris propane, 200 mM Na2SO4, 20% (w/v) PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.05 Å
R-free 0.244
|
|
4OH9
Crystal Structure of the human MST2 SARAH homodimer
Deposited 2014-01-17
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
436–484(49 aa)
Fragment:SARAH domain
Chain B
436–484(49 aa)
Fragment:SARAH domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;2.0 M NaCl, 8% polyethylene glycol (PEG) 6000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.70 Å
R-free 0.272
|
|
5BRM
Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling
Deposited 2015-05-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 15
PDB declaration: pentadecameric
|
Chain G
371–401(31 aa)
Fragment:UNP residues 371-401
Chain H
371–401(31 aa)
Fragment:UNP residues 371-401
Chain I
371–401(31 aa)
Fragment:UNP residues 371-401
Chain J
371–401(31 aa)
Fragment:UNP residues 371-401
Chain K
371–401(31 aa)
Fragment:UNP residues 371-401
Chain L
371–401(31 aa)
Fragment:UNP residues 371-401
Chain M
371–401(31 aa)
Fragment:UNP residues 371-401
Chain N
371–401(31 aa)
Fragment:UNP residues 371-401
Chain O
371–401(31 aa)
Fragment:UNP residues 371-401
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ZN ZINC ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;2.4 M Na Malonate
|
Resolution 2.65 Å
R-free 0.268
|
|
5DH3
Crystal structure of MST2 in complex with XMU-MP-1
Deposited 2015-08-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
15–313(299 aa)
Chain B
15–313(299 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
5BS 4-[(5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]benzenesulfonamide × 2
CL CHLORIDE ION × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1M Bis-Tris pH 6.5, 28% PEG3350, 0.2M (NH4)2SO4
|
Resolution 2.47 Å
R-free 0.247
|
|
6AO5
Crystal structure of human MST2 in complex with SAV1 SARAH domain
Deposited 2017-08-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
16–313(298 aa)
Fragment:kinase domain (UNP residues 16-313, 428-491)
Chain A
428–491(64 aa)
Fragment:kinase domain (UNP residues 16-313, 428-491)
|
Mutation:D146N
Mutation:D146N
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.05 M NaCl, 0.1 M Hepes, 0.19 mM CYMAL-7, 1 mM TCEP, 40% PEG 400
|
Resolution 2.96 Å
R-free 0.256
|
|
8A66
Crystal structure of MST2 in complex with XMU-MP-1
Deposited 2022-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
16–312(297 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
5BS 4-[(5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]benzenesulfonamide × 1
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2M Ammonium citrate pH 7.0 and 18% PEG3350
|
Resolution 1.90 Å
R-free 0.258
|
|
8A66
Crystal structure of MST2 in complex with XMU-MP-1
Deposited 2022-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
16–312(297 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
5BS 4-[(5,10-dimethyl-6-oxo-6,10-dihydro-5H-pyrimido[5,4-b]thieno[3,2-e][1,4]diazepin-2-yl)amino]benzenesulfonamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2M Ammonium citrate pH 7.0 and 18% PEG3350
|
Resolution 1.90 Å
R-free 0.258
|